Diagnosis and management of WM: BSH guideline
D'Sa S, et al.
Br J Haematol · 2022
Key Findings
- ●British Society for Haematology guidelines for WM diagnosis and management
- ●Recommended MYD88 and CXCR4 testing for all patients
- ●Treatment algorithm based on mutation status
Referenced in (1 disease)
Validation history
Full log →No validation events recorded yet. Source will be checked on the next kipine-source-validator run.
ID: pmid-35020191DOI: 10.1111/bjh.18036PMID: 35020191